Eight distinct CAF markers (αSMA, collagen-1, caveolin-1, CD140β, FAP, integrin α11, FSP-1 and CD90) were optimized during this study and validated on five HNSCC tumor samples. The gene discussed is CAV1; the disease is neoplasm.